INSP - NYSE

Inspire Medical Systems, Inc.

INSP·NYSE

$40.47

-0.27%

HealthcareMedical - Devices

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.17B

EPS4.9500

P/E Ratio8.18

Earnings Date08/03/2026

907.32M

Assets

12%

3Y+61.0%

5Y+223.0%

10Y+6818.0%

126.16M

Total Liabilities

3Y+83.0%

5Y+145.0%

10Y+540.0%

781.16M

Total Equity

13%

3Y+57.0%

5Y+240.0%

10Y-11921.0%

Inspire Medical Systems, Inc. Funding & Solvency Profile

INSP · NYSE

Current Assets

Cash & Cash Equivalents104.81M

Net Receivables119.69M

Inventory145.29M

Other Current Assets10.40M

Total Current Assets584 M

Non-Current Assets

Property, Plant & Equipment121.40M

Goodwill & Intangible Assets0.00

Long-Term Investments96.33M

Other Non-Current Assets6.09M

Total Non-Current Assets224 M

Total Assets

907.32M

Financial Health Analysis

Current Ratio

6.08x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.16x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

488 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

64% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Inspire Medical Systems, Inc. Balance Sheet

INSP • NYSE

Inspire Medical Systems, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	104.8M	150.2M	185.5M	441.6M	214.5M	190.5M	22.9M	97.3M	9M	6.7M
Short-Term Investments	203.5M	295.4M	274.8M	9.8M	0.0	43.8M	126.6M	90.9M	7.2M	0.0
Cash & Short-Term Investments	308.3M	445.5M	460.4M	451.4M	214.5M	234.4M	149.5M	188.2M	16.1M	6.7M
Net Receivables	119.7M	93.1M	89.9M	61.2M	34.2M	25.1M	13.1M	6.7M	3.9M	2.1M
Accounts Receivables	119.7M	93.1M	89.9M	61.2M	34.2M	25.1M	13.1M	6.7M	3.9M	2.1M
Inventory	145.3M	80.1M	33.9M	11.9M	17.2M	8.5M	5.8M	2.7M	3.7M	3.4M
Prepaids	0.0	0.0	0.0	0.0	2.7M	2M	2.2M	1.7M	426K	118K
Other Current Assets	10.4M	12.1M	9.6M	5.5M	0.0	0.0	0.0	1.7M	426K	118K
Total Current Assets	583.7M	630.8M	593.7M	530M	268.5M	269.9M	170.6M	199.3M	24.1M	12.2M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	121.4M	95.2M	62.7M	24.1M	16.4M	11.1M	4M	802K	994K	867K
Long-Term Investments	96.3M	71M	9.1M	0.0	9.9M	0.0	6.3M	0.0	0.0	0.0
Tax Assets	99.8M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	6.1M	11.3M	11.3M	10.7M	204K	204K	381K	0.0	0.0	0.0
Total Non-Current Assets	323.7M	177.6M	83.1M	34.8M	26.5M	11.3M	10.6M	802K	994K	867K
Total Assets	907.3M	808.4M	676.8M	564.9M	295.1M	281.2M	181.3M	200.1M	25.1M	13.1M
LIABILITIES
CURRENT LIABILITIES
Total Payables	39M	40.3M	39.4M	26.8M	11.7M	7.2M	4.5M	3.4M	3M	1.2M
Accounts Payable	36.6M	38.7M	38.8M	26.8M	11.7M	7.2M	4.5M	3.4M	3M	1.2M
Other Payables	2.5M	1.6M	577K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	46.5M	46.4M	38.7M	33M	20.1M	13.5M	11.6M	6.5M	3.6M	2.4M
Short Term Debt	0.0	0.0	0.0	0.0	9.2M	0.0	0.0	0.0	0.0	3.3M
Capital Lease Obligations (Current)	2.2M	1.8M	0.0	1.3M	312K	0.0	828K	0.0	0.0	0.0
Tax Payables	0.0	1.6M	577K	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	8.4M	0.0	0.0	0.0	0.0	0.0	0.0	1.2M	555K	382K
Total Current Liabilities	96.1M	88.5M	78.1M	61.2M	41.3M	20.7M	16.9M	11.2M	7.1M	7.3M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	7.5M	15.8M	24.7M	24.5M	24.9M	16.5M	12.4M
Other Non-Current Liabilities	104K	148K	1.3M	-7.4M	134K	85K	40K	0.0	157K	53K
Total Non-Current Liabilities	30.1M	30.2M	26.2M	7.7M	24.7M	30.7M	24.6M	24.9M	16.6M	12.4M
Capital Lease Obligations	32.2M	31.8M	24.8M	8.9M	9.1M	5.9M	828K	0.0	0.0	0.0
Total Liabilities	126.2M	118.7M	104.3M	68.9M	66M	51.4M	41.4M	36.1M	23.6M	19.7M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	119.1M	94.1M
Common Stock	29K	30K	30K	29K	27K	27K	24K	23K	13K	1K
Additional Paid-In Capital	927.2M	981M	917.1M	820.3M	508.5M	467M	319.9M	310.9M	7.3M	6.8M
Retained Earnings	-146.5M	-291.9M	-345.4M	-324.3M	-279.4M	-237.3M	-180.2M	-146.9M	-125.1M	-107.6M
Accumulated Other Comprehensive Income/Loss	464K	536K	800K	-86K	-55K	29K	102K	-52K	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7K
Total Stockholders' Equity	781.2M	689.7M	572.5M	496M	229M	229.7M	139.8M	164M	1.5M	-6.6M
Total Equity	781.2M	689.7M	572.5M	496M	229M	229.7M	139.8M	164M	1.5M	-6.6M
SUMMARY
Total Liabilities & Equity	907.3M	808.4M	676.8M	564.9M	295.1M	281.2M	181.3M	200.1M	25.1M	13.1M
Total Investments	299.8M	366.4M	284M	9.8M	9.9M	43.8M	132.9M	90.9M	7.2M	0.0
Total Debt	32.2M	31.8M	24.8M	16.4M	34.1M	30.6M	25.4M	24.9M	16.5M	15.7M
Net Debt	-72.7M	-118.4M	-160.7M	-425.2M	-180.4M	-159.9M	2.5M	-72.4M	7.5M	9M
Shares Outstanding	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377	29,591,377

SEC Filings

INSP - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 05, 2026	April 30, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 04, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 04, 2026	May 04, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	March 20, 2026	April 30, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 13, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	February 11, 2026	February 05, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 12, 2026	January 09, 2026	2026	View Filing
8-K 8-K 2025 N/A	November 17, 2025	November 17, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 03, 2025	September 30, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 03, 2025	November 03, 2025	2025	View Filing

Showing 1 to 10 of 142 filings

Related Guides

Blog Categories

Continue your INSP research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.